Cargando…

Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized Older Adults: A Retrospective Descriptive Study

Background. While behavioral and psychological symptoms are frequent in hospitalized older adults with dementia or delirium, data supporting the off-label use of intramuscular atypical antipsychotics remain scarce. We examined the use of short-acting intramuscular (IM) olanzapine in hospitalized old...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duong, Silvia, Yeung, Kam-Tong, Chang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458274/ https://www.ncbi.nlm.nih.gov/pubmed/26090227 http://dx.doi.org/10.1155/2015/570410

Ejemplares similares

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
por: Patel, Seema M., et al.
Publicado: (2021)

Intramuscular Olanzapine – a UK case series of early cases
por: Bushe, Chris J, et al.
Publicado: (2007)

Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness
por: Williams, Andrew M.
Publicado: (2018)

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
por: Katagiri, Hideaki, et al.
Publicado: (2018)

A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia
por: Suzuki, Hidenobu, et al.
Publicado: (2013)

Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial
por: Chan, Esther W., et al.
Publicado: (2021)

BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD) IN HOSPITALIZED OLDER ADULTS WITH AD/ADRD
por: Marziliano, Allison, et al.
Publicado: (2022)

FACTORS AFFECTING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN OLDER ADULTS WITH DEMENTIA
por: Sinwoo, Hwang, et al.
Publicado: (2019)

Management of the behavioral and psychological symptoms of dementia
por: Hersch, Elizabeth C, et al.
Publicado: (2007)

Behavioral and psychological symptoms of dementia and their management
por: Kar, Nilamadhab
Publicado: (2009)

Management of behavioral and psychological symptoms of dementia
por: Cruz Da Fonseca, I., et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
por: Katagiri, Hideaki, et al.
Publicado: (2013)

Predictors of Behavioral and Psychological Symptoms in Community-Dwelling Older Adults With Dementia
por: Kang, Bada, et al.
Publicado: (2021)

Erratum: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
por: Katagiri, Hideaki, et al.
Publicado: (2014)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Teratogenicity with Olanzapine
por: Prakash, Sathya, et al.
Publicado: (2014)

Assessment and management of behavioral and psychological symptoms of dementia
por: Kales, Helen C, et al.
Publicado: (2015)

Surgical Excision of Intramuscular Sarcomas: Description of Three Cases in Dogs
por: Olimpo, Matteo, et al.
Publicado: (2023)

Review of olanzapine in the management of bipolar disorders
por: Narasimhan, Meera, et al.
Publicado: (2007)

Behavioral and Psychological Symptoms of Dementia
por: Cerejeira, J., et al.
Publicado: (2012)

Clinical-Psychological Aspects Involved in Gynecological Surgery: Description of Peri-Operative Psychopathological Symptoms and Illness Behavior
por: Mortilla, Simona, et al.
Publicado: (2023)

Olanzapine Pamoate Use for Schizophrenia: Retrospective Records Based Study from a Tertiary Care Hospital
por: Grover, Sandeep, et al.
Publicado: (2020)

Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study
por: Ahuja, Sachin, et al.
Publicado: (2022)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

Predictors of Time to Discharge in Patients Hospitalized for Behavioral and Psychological Symptoms of Dementia
por: Kitamura, Tatsuru, et al.
Publicado: (2013)

Olanzapine Induced Hyponatraemia
por: Dudeja, Sonia J, et al.
Publicado: (2010)

Olanzapine-Induced Neutropenia
por: Malhotra, Kirti, et al.
Publicado: (2015)

Olanzapine-induced Psoriasis
por: Chepure, Ashish Hanmantrao, et al.
Publicado: (2017)

Seizure associated with olanzapine
por: Uvais, N. A., et al.
Publicado: (2018)

Intramuscular Ganglion of the Quadriceps Femoris
por: Kim, Yeung Jin, et al.
Publicado: (2013)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
por: Suresh Kumar, P. N., et al.
Publicado: (2016)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Endoscopically Assisted Resection of Intramuscular Lipoma of the Soleus
por: Lui, Tun Hing, et al.
Publicado: (2022)

Metabolic and behavioral effects of olanzapine and fluoxetine on the model organism Caenorhabditis elegans
por: Almotayri, Abdullah, et al.
Publicado: (2021)

Behavioral and Psychological Symptoms in Alzheimer's Disease
por: Li, Xiao-Ling, et al.
Publicado: (2014)

An approach to and the rationale for the pharmacological management of behavioral and psychological symptoms of dementia
por: Tripathi, Manjari, et al.
Publicado: (2010)

Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder
por: Mathys, Monica
Publicado: (2018)

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
por: Kumar, Subodh, et al.
Publicado: (2014)

Efficacy of olanzapine in symptom relief and quality of life in gastric cancer patients receiving chemotherapy
por: Nikbakhsh, Novin, et al.
Publicado: (2016)

Olanzapine-induced Cataract in a Teenage Girl
por: Lim, Chang Zhen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i9qehmkn9ecgl81sgrmpde6vju